- Investigator
- Kethandapatti Balaji
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Treats Adults
Kethandapatti Balaji, MBBS (MD), FRCS, MRCS, LRCP
Urologist
Kethandapatti Balaji, MBBS (MD), FRCS, MRCS, LRCP
(904) 383-1016
Request appointment online
Research at a glance
Research activity
Active clinical trials
- Investigator
- Kethandapatti Balaji
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Kethandapatti Balaji
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
44 publications
2022
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.
Abdominal radiology (New York)
鈥�2022
Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
鈥�2022
3JC48-3 (methyl 4鈥�-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1鈥�-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth
Cancer Gene Therapy
2022
The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis.
The Journal of urology
鈥�2022
Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
Urologic oncology
鈥�